News from CROI 2015

The annual Conference on Retroviruses and Opportunistic Infections (CROI 2015) is taking place in Seattle, USA, in late February.

Our writers will be reporting on key research presented at the conference, publishing news and sending out CROI news summary bulletins by email, three during the conference week and one the following week.

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

aidsmap news from CROI 2015

Circumcision is reducing HIV incidence in Uganda, Rakai community study shows

The growing uptake of medical male circumcision by men in the Rakai district of Uganda is leading to a substantial reduction in HIV incidence among men in

Published
27 February 2015
By
Keith Alcorn
No HIV transmissions from HIV-positive partner seen in Australian gay couples study

An Australian-based study of gay male couples of opposite HIV status (serodifferent couples) has so far seen no transmissions from the HIV-positive partner within the couple in

Published
27 February 2015
By
Gus Cairns
US PEPFAR abstinence and faithfulness funding had no impact on sexual behaviour in Africa

Nearly US$1.3 billion spent on US-funded programmes to promote abstinence and faithfulness in sub-Saharan Africa had no significant impact on sexual behaviour in 14 countries in sub-Saharan

Published
26 February 2015
By
Keith Alcorn
HIV maturation inhibitor BMS-955176 looks promising in early study

A second-generation HIV maturation inhibitor, BMS-955176, demonstrated good safety and high potency, including activity against viral strains that were not susceptible to an earlier drug in this class,

Published
26 February 2015
By
Liz Highleyman
Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows

Starting HIV treatment at a CD4 cell count above 500 reduced the risk of serious illness including tuberculosis (TB), and death, by 44% when compared to starting

Published
26 February 2015
By
Keith Alcorn
Combining PrEP and ART could almost eliminate HIV infection, east African study finds

Giving both pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) to heterosexual couples where one partner has HIV (serodiscordant couples) can almost eliminate the chance of infection in the

Published
26 February 2015
By
Gus Cairns
XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment

The vast majority of people with extensively drug-resistant tuberculosis (XDR-TB) diagnosed in the world’s most extensive outbreak have acquired their infection from another person, not as the

Published
26 February 2015
By
Keith Alcorn
Stopping cotrimoxazole during antiretroviral therapy raises risk of bacterial illness, malaria, Ugandan trial shows

Stopping cotrimoxazole prophylaxis increases the risk of serious bacterial infections and malaria, even at high CD4 cell counts, in people taking antiretroviral therapy in Uganda, results of

Published
26 February 2015
By
Keith Alcorn
Week-on, weekend-off treatment controls viral load in young people

Taking an efavirenz-based antiretroviral regimen during the week and taking no medication on two days over the weekend was just as effective as daily treatment in controlling

Published
25 February 2015
By
Keith Alcorn
PrEP use rising in San Francisco, but scaling up could further cut new infections

Use of Truvada (tenofovir/emtricitabine) pre-exposure prophylaxis, better known as PrEP, is increasing in San Francisco, but it is still only reaching about one-third of people who could benefit,

Published
25 February 2015
By
Liz Highleyman
← Prev12345Next →

Email bulletins

Sign up for our conference bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.